5-phenyl-2,3-dihydro-1H-1,4-benzodiazepine结构式
|
常用名 | 5-phenyl-2,3-dihydro-1H-1,4-benzodiazepine | 英文名 | 5-phenyl-2,3-dihydro-1H-1,4-benzodiazepine |
|---|---|---|---|---|
| CAS号 | 2898-20-6 | 分子量 | 222.28500 | |
| 密度 | N/A | 沸点 | N/A | |
| 分子式 | C15H14N2 | 熔点 | N/A | |
| MSDS | N/A | 闪点 | N/A |
| 英文名 | 5-phenyl-2,3-dihydro-1H-1,4-benzodiazepine |
|---|---|
| 英文别名 | 更多 |
| 分子式 | C15H14N2 |
|---|---|
| 分子量 | 222.28500 |
| 精确质量 | 222.11600 |
| PSA | 24.39000 |
| LogP | 2.52310 |
| InChIKey | MDPJHNGFYGSHME-UHFFFAOYSA-N |
| SMILES | c1ccc(C2=NCCNc3ccccc32)cc1 |
|
~59%
5-phenyl-2,3-di... 2898-20-6 |
| 文献:Guandalini; Balliu; Cellai; Martino; Nebbioso; Mercurio; Carafa; Bartolucci; Dei; Manetti; Teodori; Scapecchi; Altucci; Paoletti; Romanelli European Journal of Medicinal Chemistry, 2013 , vol. 66, p. 56 - 68 |
|
~%
5-phenyl-2,3-di... 2898-20-6 |
| 文献:SMITHKLINE BEECHAM CORPORATION Patent: WO2006/44753 A2, 2006 ; Location in patent: Page/Page column 50 ; WO 2006/044753 A2 |
| 1H-1,4-Benzodiazepine,2,3-dihydro-5-phenyl |
| 2,3-Dihydro-5-phenyl-1H-1,4-benzodiazepin |
| 5-phenyl-1,3-dihydro-1,4-benzodiazepine |
| 5-Phenyl-2,3-dihydro-1H-1,4-benzodiazepin |
| 5-Phenyl-1,2-dihydro-3H-1,4-benzodiazepin |